We’re proud to share that Dr Ravi Jain has been appointed UK Relfydess Trainer, leading the clinical education for this next-generation botulinum toxin on behalf of Galderma. This appointment recognises his expertise, commitment to ethical aesthetic medicine, and his role in shaping the future of advanced injectables in the UK.

Why Relfydess Is a Breakthrough

Relfydess isn’t just another wrinkle-relaxing injection. It’s the result of years of scientific innovation, representing a new chapter in aesthetic pharmaceuticals. Designed with next-generation neuromodulator science, Relfydess offers enhanced precision, consistent results, and a more comfortable experience for patients.

For aesthetic practitioners, it also brings exciting advances in onset time, longevity, and spread characteristics—backed by robust clinical research and trial data.

What This Means for UK Aesthetics

Dr Jain’s appointment as UK Relfydess Trainer comes at a pivotal time. As the demand for safe, subtle, and doctor-led injectables continues to grow across Harpenden, St Albans, and Luton, this new training role ensures that Riverbanks Clinic remains at the forefront of education, safety, and innovation.

Accordingly, UK practitioners will now benefit from Dr Jain’s:

• Extensive aesthetic experience since 2005
• Innovative training techniques, developed over a decade of global teaching
• Ethical approach to injectables, focusing on natural-looking, regenerative results
• Commitment to evidence-based medicine, ensuring new treatments are backed by data, not hype

Training Backed by a Globally Used Clinical Framework

One of the key reasons Galderma selected Dr Jain as a UK Relfydess Trainer is his contribution to the field of aesthetic medicine beyond injectables. He is the creator of the Facial Assessment Scale, a framework now used globally by advanced aesthetic doctors and nurses to deliver fully customised, ethical treatment plans for patients.

This Facial Assessment Scale enables practitioners to:

• Evaluate facial proportions with clinical precision
• Tailor treatment protocols based on individual facial dynamics
• Track improvements over time using objective criteria
• Deliver consistent results that align with patient expectations

“Too many treatments are based on trend rather than anatomy,” says Dr Jain. “The Facial Assessment Scale ensures we put structure and science before syringes.”

By incorporating this structured approach into the Relfydess training curriculum, Dr Jain is equipping UK practitioners with the same gold-standard tools used by world leaders in aesthetics.

Training That Goes Beyond the Needle

Relfydess represents more than just technical training. Under Dr Jain’s guidance, practitioners will learn:

• How to assess facial anatomy holistically
• The ethical consultation process for long-term patient satisfaction
• How to integrate Relfydess into full facial balancing protocols
• Managing complications and setting patient expectations
• Incorporating regenerative treatments alongside neurotoxins

These trainings will be delivered both nationally and regionally, and they aim to elevate the standard of care across all levels of practice—from medical aesthetics clinics to larger healthcare groups.

What Sets Relfydess Apart?

According to the READY clinical programme, Relfydess provides:

• Rapid onset: noticeable results within 24–48 hours
• High patient satisfaction: sustained effects for 4–6 months in many cases
• Refined diffusion: precise targeting with minimal spread, especially useful for fine-tuning facial symmetry
• Stability: designed for consistent efficacy even after reconstitution

This makes Relfydess ideal for treating complex dynamic areas like:

• Crow’s feet
• Glabellar lines
• Forehead lines
• Jawline tension
• Neck bands

And as Dr Jain puts it:

“We’re entering an era where patients want more control over their look—faster onset, softer finishes, and longer-lasting freshness. Relfydess delivers that with scientific precision.”

Backed by Galderma’s Research Legacy

Relfydess is developed by Galderma, the world’s largest independent dermatology company. Their reputation for advancing medical skincare, injectables, and prescription solutions adds even more credibility to this launch.

Galderma is also known for championing scientific integrity, global education, and ethical partnerships—values that align strongly with Riverbanks Clinic.

Dr Jain’s Aesthetic Philosophy

Dr Ravi Jain has built his career on the philosophy of invisible aesthetics—delivering results that are noticeable only by their natural harmony. As the founder of Riverbanks Clinic and a respected international speaker, Dr Jain advocates for:

• Medical-grade injectables under doctor supervision
• Avoiding overfilled, over-frozen appearances
• Restoring, not transforming
• Teaching future clinicians to listen first, inject later

His methods have been taught to practitioners in Australia, Malaysia, the UK, and across Europe, and now, with this new appointment, he brings those standards home to the UK Relfydess training programme.

Local Leadership, Global Reach

While Relfydess is launching globally, the UK launch begins in May 2025, with the official Scottish debut in Glasgow on 17th June, led by Dr Jain. His appointment ensures that Harpenden, Luton, and St Albans clinicians and patients will be among the first in the country to benefit from this world-class innovation.

The Future of Injectables Is Here

Whether you’re a practitioner eager to learn more about Relfydess or a patient looking for more refined treatment options, this launch marks a turning point. With Dr Jain at the helm, training will focus on long-term outcomes, patient safety, and regenerative strategies—not just wrinkle reduction.

As he says:

“A good injector gives you what you ask for. A great injector teaches you what to ask for. That’s the ethos we’re building with Relfydess.”

Subscribe to the blog

Get the latest articles sent straight to your inbox

First Name *

Last Name *

Email *

Phone Number

Where did you hear about us? *

Please select oneAdvertismentAnother ClientConferenceFacebookGooglePressRadioWebinar

I have read and agree to the privacy policy *

YES

 

Submit